'QIAGEN Supplementary Protocol: Fast-forward protocol for transient transfection of 293 cells in 96-well plates using Effectene Transfection Reagent', [Online] 01 November 2006, XP055030573 Retrieved from the Internet: <URL:www.qiagen.com> [retrieved on 2012-06-21] (B1)

WUSTMAN ET AL: "114. Pharmacological chaperone therapy for Gaucher disease: Mechanism of action, a survey of responsive mutations and phase I clinical trial results" MOLECULAR GENETICS AND METABOLISM, vol. 93, no. 2, 14 January 2008 (2008-01-14), page 44, XP022420747 ACADEMIC PRESS, SAN DIEGO, CA, US ISSN: 1096-7192 DOI: 10.1016/J.YMGME.2007.10.126 (B1)

'QIAGEN Supplementary Protocol: Transient transfection of COS-7 cells in 96-well plates using PolyFect Transfection Reagent', [Online] 01 January 2001, XP055030566 Retrieved from the Internet: <URL:www.qiagen.com/literature/render.aspx? id=543> [retrieved on 2012-06-21] (B1)

'Transfecting Plasmid DNA into COS-7 Cells Using Lipofectamine(TM) LTX Reagent', [Online] 09 June 2006, XP055030567 Retrieved from the Internet: <URL:www.invitrogen.com> [retrieved on 2012-06-21] (B1)

'Transfecting Plasmid DNA into GripTite(TM) 293 MSR Cells Using Lipofectamine(TM) LTX Reagent', [Online] 01 January 2006, XP055030581 Retrieved from the Internet: <URL:http://www.invitrogen.com/etc/medialib /en/filelibrary/pdf/protocols.Par.18853.Fil e.dat/Human_embryonic_kidney.pdf> [retrieved on 2012-06-21] (B1)

'Transfecting Plasmid DNA into HEK 293 Cells Using Lipofectamine(TM) LTX Reagent', [Online] 01 January 2006, XP055030576 Retrieved from the Internet: <URL:www.invitrogen.com> [retrieved on 2012-06-21] (B1)

ALFONSO ET AL: "Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations" BLOOD CELLS, MOLECULES AND DISEASES, vol. 35, no. 2, 1 September 2005 (2005-09-01), pages 268-276, XP005074539 LAJOLLA, US ISSN: 1079-9796 DOI: 10.1016/J.BCMD.2005.05.007 (B1)

FAN J-Q ET AL: "Accelerated transport and maturation of lysosomal .alpha.-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor" NATURE MEDICINE, vol. 5, no. 1, 1 January 1999 (1999-01-01), pages 112-115, XP002293424 NATURE PUBLISHING GROUP, NEW YORK, NY, US ISSN: 1078-8956 DOI: 10.1038/4801 (B1)

FAN J-Q ET AL: "Cell-based screening of active-site specific chaperone for the treatment of Fabry disease" METHODS IN ENZYMOLOGY, vol. 363, 1 January 2003 (2003-01-01), pages 412-420, XP008110443 ACADEMIC PRESS INC, SAN DIEGO, CA, US ISSN: 0076-6879 DOI: 10.1016/S0076-6879(03)01069-3 (B1)

LEI ET AL: "Enzyme enhancement activity of N-octyl-beta-valienamine on beta-glucosidase mutants associated with Gaucher disease" BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE, vol. 1772, no. 5, 18 April 2007 (2007-04-18), pages 587-596, XP022033473 AMSTERDAM, NL ISSN: 0925-4439 DOI: 10.1016/J.BBADIS.2007.02.003 (B1)

SHIMOTORI MASAAKI ET AL: "Novel mutations of the GLA gene in Japanese patients with Fabry disease and their functional characterization by active site specific chaperone" HUMAN MUTATION, vol. 29, no. 2, 18 January 2008 (2008-01-18), pages 1-10, XP002623557 ISSN: 1059-7794 (B1)

SHIN ET AL: "Screening for pharmacological chaperones in Fabry disease", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 359, no. 1, 2 June 2007 (2007-06-02), pages 168-173, XP022103159, ISSN: 0006-291X, DOI: DOI:10.1016/J.BBRC.2007.05.082 (B1)

US-A1- 2005 203 019 (B1)

US-A1- 2006 264 467 (B1)

US-A1- 2007 021 381 (B1)

US-A1- 2007 270 486 (B1)

WO-A1-99/62517 (B1)

WO-A2-2007/137072 (B1)

WU XIAOYANG ET AL: "A pharmacogenetic approach to identify mutant forms of [alpha]-galactosidase A that respond to a pharmacological chaperone for Fabry disease.", HUMAN MUTATION AUG 2011, vol. 32, no. 8, August 2011 (2011-08), pages 965-977, ISSN: 1098-1004 (B1)

'QIAGEN Supplementary Protocol: Transient transfection of 293 cells in 96-well plates using PolyFect Transfection Reagent', [Online] 01 August 2001, XP055030574 Retrieved from the Internet: <URL:www.qiagen.com> [retrieved on 2012-06-21] (B1)